Skip to main content

Table 3 Predicted and actual breakpoints from each sample

From: Detection of DNA fusion junctions for BCR-ABL translocations by Anchored ChromPET

  Prediction Break point Actual Difference (bp)
Sample M-BCR ABL1   M-BCR ABL1 M-BCR ABL1
K562 110,194-110,207 27,762-27,909 BCR-ABL1 110,191-110,192 27,878-27,879 3 0
KU812 110,241-110,242 63,843-63,853 BCR-ABL1 110,299-110,300 63,929-63,930 57 76
    ABL1-BCR 110,096-110,097 63,804-63,805 144 38
Patient 1 109,790-109,830 125,280-125,623 BCR-ABL1 109,781-109,782 125,326-125,327 8 0
    ABL1-BCR 109,670-109,671 149,445-149,446 119 a23,822
Patient 2 109,702-109,867 102,484-102,653 BCR-ABL1 109,834-109,835 102,524-102,525 0 0
    ABL1-BCR 109,869-109,870 102,526-102,527 2 0
  1. Predicted and actual breakpoints for each sample. The absolute difference (in base pairs) between predicted breakpoint site and sequenced breakpoint site is shown in the last two columns. All M-bcr coordinates are relative to chr22:23,522,552 (start position of BCR gene). All ABL1 coordinates are relative to chr9:133,586,268 (start position of ABL1 gene). aWe had a secondary peak at this locus in the patient 1 ABL1 breakpoint profile (Figure S3D in Additional file 1).